Galapagos制药 GLPG 深 沪
已收盘 10-24 16:00:00 美东时间
31.96
-0.070
-0.22%
华盛通- 最 高32.525
- 今 开32.40
- 成交量 13.43万股
- 最 低 31.95
- 昨 收 32.03
- 总市值 21.06亿
- 52周最高 37.78
- 市盈率 静 26.38
- 换手率 0.00%
- 52周最低 22.36
- 委 比 31.51%
- 总股本 6589.71万
- 历史最高 274.03
- 量 比 0.38
- 振 幅 1.80%
- 历史最低 13.023
- 每 手 1
- 风险率 3.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
美股大行评级 | 富国银行上调苹果目标价升至290美元；"卖出"！花旗下调NuScale Power、阿特斯太阳能评级
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从30美元升至44美元；Piper Sandler：维持Vital Energy"中性"评级，目标价从16美元升至30美元
10-22 10:10
Leerink Partners Upgrades Galapagos to Outperform, Raises Price Target to $40
Leerink Partners analyst Faisal Khurshid upgrades Galapagos (NASDAQ:GLPG) from Market Perform to Outperform and raises the price target from $29 to $40.
10-22 04:43
Galapagos falls after plans to shut down cell therapy unit
Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U...
10-21 19:40
又一家企业终止细胞治疗，裁员逾300人，波及上海团队
（来源：药研网） 10月21日，比利时生物技术公司 Galapagos NV宣布，将全面停止其细胞治疗业务。若该终止计划最终落实，此次调整将波及公司在欧洲、美国...
10-21 15:38
Galapagos Plans To Wind Down Cell Therapy Business And Redirect Cash Toward Transformational Deals
Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos
10-21 14:00
Galapagos updates on strategic alternatives for cell therapy business
Galapagos (NASDAQ:GLPG) said on Wednesday that its board had decided to explore all strategic alternatives for its cell therapy business , including a potential divestiture of the Cell Therapy Busines...
10-02 04:46
Galapagos NV Advances Cell Therapy Business Divestment Review; Expects Decision By November 5, 2025
Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV ((Euronext &, NASDAQ:GLPG) and its Board of Directors today issued the following statement:On May 13, 2025, Galapagos announced that its Board of Directors
10-02 04:02
Galapagos NV Secures FDA RMAT Designation for GLPG5101
Galapagos ( ($GLPG) ) has shared an announcement. On August 6, 2025, Galapagos ...
08-06 18:55
Galapagos shares are trading lower after the company reported worse-than-expected Q2 EPS results.
Galapagos shares are trading lower after the company reported worse-than-expect...
07-24 22:56
